Jean-paul Kress - Net Worth and Insider Trading

Jean-paul Kress Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jean-paul Kress owns 2 companies in total, including Sarepta Therapeutics Inc (SRPT) , and Biogen Inc (BIIB) .

Click here to see the complete history of Jean-paul Kress’s form 4 insider trades.

Insider Ownership Summary of Jean-paul Kress

Ticker Comapny Transaction Date Type of Owner
SRPT Sarepta Therapeutics Inc 2015-09-29 director
BIIB Biogen Inc 2017-06-14 EVP Pres Int'l & Global Hd GTO

Jean-paul Kress Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jean-paul Kress Ownership Network

Ownership Network List of Jean-paul Kress

No Data

Ownership Network Relation of Jean-paul Kress

Jean-paul Kress Owned Company Details

What does Sarepta Therapeutics Inc do?

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Who are the key executives at Sarepta Therapeutics Inc?

Jean-paul Kress is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , SVP & General Counsel Ryan Edward Brown , and Chief Financial Officer Ian Michael Estepan .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Jean-paul Kress made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 103,270 shares made by Michael Andrew Chambers , a net purchase of 25,026 shares made by Douglas S Ingram , and a net purchase of 3,780 shares made by Louise Rodino-klapac .

In summary, during the past 3 months, insiders sold 0 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 858 shares of Sarepta Therapeutics Inc (SRPT) were sold and 132,076 shares were bought by its insiders, resulting in a net purchase of 131,218 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.


Sarepta Therapeutics Inc Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Jean-paul Kress Mailing Address

Above is the net worth, insider trading, and ownership report for Jean-paul Kress. You might contact Jean-paul Kress via mailing address: 215 First Street, Suite 415, Cambridge Ma 02142.